Intake of Energy Drinks Before and During Pregnancy and Adverse Pregnancy Outcomes

被引:5
|
作者
Ding, Ming [1 ,2 ]
Markon, Andre O. [3 ]
Jones-Dominic, Olivia E. [3 ]
Purdue-Smithe, Alexandra C. [4 ,5 ]
Rich-Edwards, Janet W. [4 ,5 ]
Wolpert, Beverly J. [3 ]
Chavarro, Jorge E. [2 ,5 ,6 ,7 ,8 ]
机构
[1] Univ N Carolina, Dept Emergency Med, Chapel Hill, NC USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA
[3] US FDA, Ctr Food Safety & Appl Nutr, Off Analyt & Outreach, College Pk, MD USA
[4] Brigham & Womens Hosp, Div Womens Hlth, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
[6] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA
[7] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[8] Harvard TH Chan Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA
关键词
HYPERTENSIVE DISORDERS; DIETARY QUESTIONNAIRE; HEALTH; CONSUMPTION; VALIDITY; REPRODUCIBILITY; VALIDATION; DISEASE; IMPACT; RISK;
D O I
10.1001/jamanetworkopen.2023.44023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance: Consumption of energy drinks has increased drastically in recent years, particularly among young people. It is unknown whether intake of energy drinks is associated with health during pregnancy.Objective: To examine associations of energy drink intake before and during pregnancy with risk of adverse pregnancy outcomes (APOs).Design, setting, and participants: This prospective cohort study included data from women enrolled in the Nurses' Health Study 3 (NHS3) between June 1, 2010, and September 27, 2021, and the Growing Up Today Study (GUTS) who reported 1 or more singleton pregnancy from January 1, 2011, to June 1, 2019. Data were analyzed from October 1, 2021, to September 28, 2023.Exposure: Intake of energy drinks, assessed by food frequency questionnaire.Main outcomes and measures: The main outcomes were self-reported APOs, including pregnancy loss, gestational diabetes, gestational hypertension, preeclampsia, or preterm birth, and a composite APO, defined as development of any of the APOs. Risk of APOs was compared between consumers and nonconsumers of energy drinks.Results: This study included 7304 pregnancies in 4736 participants with information on prepregnancy energy drink intake and 4559 pregnancies in 4559 participants with information on energy drink intake during pregnancy. There were 1691 GUTS participants (mean [SD] age, 25.7 [2.9] years) and 3045 NHS3 participants (mean [SD] age, 30.2 [4.1] years). At baseline, 230 GUTS participants (14%) and 283 NHS3 participants (9%) reported any intake of energy drinks. While no associations were found for pregnancy loss (odds ratio [OR], 0.89; 95% CI, 0.71-1.11), preterm birth (OR, 1.07; 95% CI, 0.71-1.61), gestational diabetes (OR, 0.89; 95% CI, 0.58-1.35), preeclampsia (OR, 0.73; 95% CI, 0.41-1.30), or the composite APO (OR, 1.05; 95% CI, 0.87-1.26), prepregnancy energy drink use was associated with a higher risk of gestational hypertension (OR, 1.60; 95% CI, 1.12-2.29). A significant interaction was found between age and energy drink intake in relation to hypertensive disorders (P = .02 for interaction for gestational hypertension; P = .04 for interaction for any hypertensive disorders), with stronger associations for participants above the median age. No associations of energy drink intake during pregnancy with any of the APOs were found in NHS3 (eg, any APO: OR, 0.86; 95% CI, 0.41-1.79).Conclusions and relevance: In this study, energy drink intake before pregnancy was associated with an elevated risk of gestational hypertension. Given the low prevalence of energy drink intake and low consumption levels among users, the results should be interpreted cautiously.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Caffeine intake during pregnancy and adverse outcomes: An integrative review
    Rohweder, Ricardo
    Schmalfuss, Thanyse de Oliveira
    Borniger, Diessy dos Santos
    Ferreira, Carolina Zanfir
    Zanardini, Marcos Kobren
    Lopes, Guilherme Paulon Torrano Ferreira
    Barbosa, Camila Pocharski
    Moreiraa, Taiane Dornelles
    Schuler-Faccini, Lavinia
    Sanseverino, Maria Teresa Vieira
    da Silva, Andre Anjos
    Abeche, Alberto Mantovani
    Luiz, Fernanda Sales
    Rosa, Lucas
    REPRODUCTIVE TOXICOLOGY, 2024, 123
  • [2] Optimal timing of periodontal disease treatment for prevention of adverse pregnancy outcomes: before or during pregnancy?
    Xiong, Xu
    Buekens, Pierre
    Goldenberg, Robert L.
    Offenbacher, Steven
    Qian, Xu
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (02) : 111.e1 - 111.e6
  • [3] Residence change during pregnancy and adverse pregnancy outcomes
    Goulding, Alison N.
    Sangi-Haghpeykar, Haleh
    Johnson, Grace J.
    Shanahan, Matthew A.
    Detlefs, Sarah E.
    Aagaard, Kjersti M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S468 - S468
  • [4] Experiences of violence before and during pregnancy and adverse pregnancy outcomes: An analysis of the Canadian Maternity Experiences Survey
    Urquia, Marcelo L.
    O'Campo, Patricia J.
    Heaman, Maureen I.
    Janssen, Patricia A.
    Thiessen, Kellie R.
    BMC PREGNANCY AND CHILDBIRTH, 2011, 11
  • [5] Experiences of violence before and during pregnancy and adverse pregnancy outcomes: An analysis of the Canadian Maternity Experiences Survey
    Marcelo L Urquia
    Patricia J O'Campo
    Maureen I Heaman
    Patricia A Janssen
    Kellie R Thiessen
    BMC Pregnancy and Childbirth, 11
  • [6] Adverse pregnancy outcomes associated with antiretroviral therapy initiated before pregnancy and during pregnancy: a retrospective study in Hubei province, China
    Tan, Yuting
    Wu, Songjie
    Yan, Yajun
    Zou, Shi
    Feng, Ling
    Guo, Wei
    Wu, Mengmeng
    Luo, Mingqi
    Liang, Ke
    FRONTIERS IN MEDICINE, 2023, 10
  • [7] Partner violence during pregnancy and risk of adverse pregnancy outcomes
    Coker, AL
    Sanderson, M
    Dong, B
    PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2004, 18 (04) : 260 - 269
  • [8] Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes
    Rebordosa, Cristina
    Kogevinas, Manolis
    Bech, Bodil H.
    Sorensen, Henrik T.
    Olsen, Jorn
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2009, 38 (03) : 706 - 714
  • [9] Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes
    Berard, Anick
    Zhao, Jin-Ping
    Shui, Irene
    Colilla, Susan
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (04) : 500 - 509
  • [10] Listeria monocytogenes and diet during pregnancy; balancing nutrient intake adequacy v. adverse pregnancy outcomes
    Pezdirc, Kristine B.
    Hure, Alexis J.
    Blumfield, Michelle L.
    Collins, Clare E.
    PUBLIC HEALTH NUTRITION, 2012, 15 (12) : 2202 - 2209